Question 1

How big is the Global Shrimp Disease Diagnostics market?

Accepted Answer

According to Value Market Research, the Global Shrimp Disease Diagnostics market size was estimated at USD 540.23 Million in 2025 and is expected to reach USD 602.73 Million in 2026.

Question 2

What is the Global Shrimp Disease Diagnostics market growth?

Accepted Answer

The Global Shrimp Disease Diagnostics market is expected to grow at a CAGR of 11.57% from 2026-2034 to reach USD 1447.12 Million by 2034.

Question 3

Which country holds the highest share in the Global Shrimp Disease Diagnostics market?

Accepted Answer

Asia Pacific held the highest share in the Global Shrimp Disease Diagnostics market.

Question 4

How is the Global Shrimp Disease Diagnostics market segmented in the report?

Accepted Answer

The Global Shrimp Disease Diagnostics market is segmented By Disease (Taura Syndrome Virus, Yellow Head or Gill Associated Virus, Early Mortality Syndrome, White Spot Syndrome Virus, Other), By Kits (Assay Based Kit, Rapid Testing Kit), By End User (Fisheries, Aquaculture and Marine Laboratories, Education and Research Institutes).

Question 5

Who are the key players in the Global Shrimp Disease Diagnostics market?

Accepted Answer

Some key players include Fujikura Kasei Co.Ltd., GeneReach Biotechnology Corp., Thermo Fisher Scientific Inc., Aura Biotechnologies and Lab Ind Resource Sdn Bhd.

Question 6

What are the factors driving the shrimp disease diagnostics market?

Accepted Answer

Key drivers include rising incidences of shrimp diseases such as Early Mortality Syndrome, increasing demand for high-quality aquaculture production, advancements in molecular diagnostic technologies, and growing investments in shrimp farming sustainability and biosecurity management.

Question 7

Which segment accounted for the largest shrimp disease diagnostics market share by end user?

Accepted Answer

The fisheries segment dominated the market with a share of 40.99% in 2025, driven by the growing adoption of disease monitoring practices, rising shrimp farming activities, and increasing demand for early diagnostic testing to minimize disease outbreaks and improve farm productivity.